See more : Logistics Innovation Technologies Corp. (LITT) Income Statement Analysis – Financial Results
Complete financial analysis of InnerScope Hearing Technologies, Inc. (INND) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InnerScope Hearing Technologies, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- The PNC Financial Services Group, Inc. (0KEF.L) Income Statement Analysis – Financial Results
- Sirca Paints India Limited (SIRCA.BO) Income Statement Analysis – Financial Results
- InterPrivate IV InfraTech Partners Inc. (IPVIW) Income Statement Analysis – Financial Results
- Sunny Loan Top Co.,Ltd. (600830.SS) Income Statement Analysis – Financial Results
- Cheviot Company Limited (CHEVIOT.BO) Income Statement Analysis – Financial Results
InnerScope Hearing Technologies, Inc. (INND)
About InnerScope Hearing Technologies, Inc.
InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates 11 audiological and retail hearing device clinics; and offers business to business SaaS based patient management system software program. The company was formerly known as Innerscope Advertising Agency, Inc. and changed its name to InnerScope Hearing Technologies, Inc. in August 2017. InnerScope Hearing Technologies, Inc. was incorporated in 2012 and is headquartered in Roseville, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.69M | 15.28M | -3.76K | 166.11K | 847.11K | 324.88K | 470.63K | 1.90M | 872.33K | 678.40K | 445.93K |
Cost of Revenue | 509.07K | 9.52M | 1.55M | 68.77K | 496.74K | 181.69K | 293.22K | 776.61K | 143.48K | 516.64K | 346.39K |
Gross Profit | 3.19M | 5.77M | -1.55M | 97.34K | 350.37K | 143.19K | 177.41K | 1.12M | 728.85K | 161.76K | 99.55K |
Gross Profit Ratio | 86.22% | 37.74% | 41,150.37% | 58.60% | 41.36% | 44.07% | 37.70% | 59.08% | 83.55% | 23.84% | 22.32% |
Research & Development | 0.00 | 127.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 1.39M | 1.18M | 3.46M | 2.67M | 1.34M | 1.08M | 626.76K | 73.68K | 99.51K |
Selling & Marketing | 0.00 | 0.00 | 74.31K | 19.76K | 485.41K | 173.58K | 0.00 | 0.00 | 0.00 | 79.60K | 57.21K |
SG&A | 2.08M | 4.73M | 1.48M | 1.20M | 3.95M | 2.84M | 1.34M | 1.08M | 626.76K | 201.28K | 177.72K |
Other Expenses | 0.00 | 0.00 | 0.00 | 123.65K | 150.02K | 1.30M | 0.00 | 1.14K | 14.47K | 0.00 | 0.00 |
Operating Expenses | 2.08M | 4.86M | 1.48M | 1.33M | 4.10M | 2.84M | 1.34M | 1.08M | 641.24K | 201.28K | 177.72K |
Cost & Expenses | 2.59M | 14.38M | 3.03M | 1.40M | 4.59M | 3.02M | 1.63M | 1.85M | 784.72K | 717.92K | 524.11K |
Interest Income | 0.00 | 0.00 | 114.42 | 1.71K | 3.34K | 0.00 | 300.00 | 317.00 | 308.00 | 306.00 | 197.00 |
Interest Expense | 2.81M | 3.01M | 1.42M | 1.71M | 3.34M | 1.27M | 77.29K | 2.15K | 308.00 | 0.00 | 0.00 |
Depreciation & Amortization | 254.65K | 460.29K | 90.68K | 123.65K | 317.39K | 5.81K | 884.00 | 184.00 | 308.00 | 39.52K | 78.17K |
EBITDA | -7.91M | 9.04M | 1.54M | -1.09M | -3.60M | -3.31M | -1.84M | 44.81K | 87.92K | 306.00 | 197.00 |
EBITDA Ratio | -213.99% | 8.96% | 78,158.08% | -665.47% | -425.16% | -429.46% | -246.80% | 2.38% | 10.08% | 0.05% | 0.04% |
Operating Income | 1.11M | 909.14K | -3.03M | -1.23M | -3.74M | -2.71M | -1.23M | 44.63K | 87.61K | -39.52K | -78.17K |
Operating Income Ratio | 29.94% | 5.95% | 80,567.22% | -740.01% | -442.07% | -833.74% | -260.61% | 2.35% | 10.04% | -5.83% | -17.53% |
Total Other Income/Expenses | -12.08M | 4.67M | 2.19M | -3.72M | -4.18M | -1.88M | -686.84K | 62.17K | 308.00 | 306.00 | 197.00 |
Income Before Tax | -10.98M | 5.58M | 34.37K | -4.95M | -7.92M | -4.59M | -1.91M | 106.80K | 87.92K | -39.21K | -77.98K |
Income Before Tax Ratio | -297.05% | 36.48% | -913.02% | -2,982.16% | -935.46% | -1,411.34% | -406.55% | 5.63% | 10.08% | -5.78% | -17.49% |
Income Tax Expense | -10.98M | -2.00 | 4.00 | 1.71M | 3.33M | -607.20K | -609.55K | 37.05K | 17.06K | 306.00 | 197.00 |
Net Income | -10.98M | 5.58M | 34.37K | -6.67M | -11.26M | -4.59M | -1.91M | 69.74K | 70.85K | -39.21K | -77.98K |
Net Income Ratio | -297.05% | 36.48% | -913.02% | -4,012.96% | -1,329.08% | -1,411.34% | -406.55% | 3.68% | 8.12% | -5.78% | -17.49% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.06 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.06 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 5.82B | 6.92B | 6.79B | 3.63B | 187.68M | 78.89M | 61.32M | 60.91M | 60.91M | 60.70M | 61.00M |
Weighted Avg Shares Out (Dil) | 5.82B | 6.92B | 6.79B | 3.63B | 187.68M | 78.89M | 61.32M | 60.91M | 60.91M | 60.61M | 60.91M |
InnerScope Hearing Technologies (OTC:INND) Launches its iHEAR Matrix OTC Hearing Aids in 4218 Walmart Stores
InnerScope Hearing Technologies Inc. (OTC:INND) President and CEO Matthew Moore Discusses the Company's Business Model and Target Markets in SmallCapVoice Interview
InnerScope Hearing Technologies (OTC: INND) Retains SmallCapVoice.com to Amplify Investor Relations and Digital Marketing Initiatives
InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of OTC Rechargeable Hearing Aids on Walgreens.com
InnerScope Hearing Technologies (OTC: INND) CEO to Present at The Emerging Growth Conference on June 8, 2022
InnerScope Hearing Technologies (OTC: INND) CEO to Present at The Emerging Growth Conference on Jan. 5, 2022
INND Stock: Why The Price Surged
InnerScope Hearing Technologies (OTC: INND) Acquires iHEAR Medical
InnerScope Hearing Technologies (OTC: INND) to Participate in the Virtual Home Health & Diabetes Care Program, Sept. 20–23, 2021
InnerScope Hearing Technologies: Bringing Hearing Devices to Those in Need
Source: https://incomestatements.info
Category: Stock Reports